Furthermore, gene expression studies in combination with disease association can nominate transcriptional regulatory mechanisms as a testable culprit for novel AD GWAS loci, such as CLU, ABCA7 and MS4A4A, as discussed. This evidence concerns the gene MS4A4A and Alzheimer disease.